FluoGuide is trading at SEK 33.10, down 5.97%, amid broader risk sentiment weakness.
- No company-specific announcement or fresh catalyst was identified for September 14, 2026; the latest listed release remains FluoGuide’s August 25, 2026 interim report.
- Nasdaq futures are down 1.84% and S&P 500 futures 0.84%, potentially pressuring risk-sensitive biotechnology shares.
- The specific cause remains unconfirmed, so this appears to be a global-market move rather than a FluoGuide event.